Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

In8bio, Inc.

Biological Products, (No Diagnostic Substances) · New York, NY, United States

  1. PrincipalsKate RochlinChief Operating OfficerPatrick McCallCHIEF FINANCIAL OFFICERWilliam Tai-Wei HoPRESIDENT AND CEOand 4 more
  2. CompanyIn8bio, Inc.New York, NY, United States
  3. Phone line+1 (646) 600-6438General business
Request a quote

In8bio, Inc. is an SEC-registered Nasdaq-listed company (ticker INAB) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 7

Chief executive

William Tai-Wei HoPRESIDENT AND CEO

Chair & board

Alan S. RoemerDirector (Board)
Emily FairbairnDirector (Board)
Peter C. BrandtDirector (Board)

Finance

Patrick McCallCHIEF FINANCIAL OFFICER

Operations

Kate RochlinChief Operating Officer
Everyone else on file (1)
Lawrence LambEVP and CSO

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Kate Rochlin — Chief Operating Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Patrick McCall — CHIEF FINANCIAL OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. William Tai-Wei Ho — PRESIDENT AND CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers